Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

NCT ID: NCT07231419
Registry status: Recruiting
Study type: Not specified in the registry data
Phase: Phase 3
Sponsor: Vertex Pharmaceuticals Incorporated

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 734 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages: Not specified in the registry data
Sex: Not specified in the registry data
Healthy volunteers accepted: No

ClinicalTrials.gov lists the following eligibility criteria.

Key Inclusion Criteria: * Body weight greater than or equal to (≥)45 kilogram (kg) * Body mass index (BMI) ≥18 to less than (\<) 40 kilogram per meter square (kg/m\^2) * Diagnosis of diabetes mellitus type 1 or type 2 and with glycosylated hemoglobin A1c (HbA1c) ≤9% and the presence of bilateral pain in lower extremities due to DPN for at least 1 year * Weekly average of daily NPRS score ≥4 and less than or equal to (≤) 9 with limited variation in the 7-day Baseline Period Key Exclusion Criteria: * More than 3 missing daily NPRS scores during the 7-day Baseline Period * Received Journavx within 30 days of study drug dosing * Any sensory abnormality (excluding DPN) as pre-specified in the protocol Other protocol defined Inclusion/Exclusion criteria may apply.

Study locations

75 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

Alabama, United States: 3
Arizona, United States: 2
Arkansas, United States: 1
California, United States: 8
Colorado, United States: 2
Connecticut, United States: 1
District of Columbia, United States: 1
Florida, United States: 13
Georgia, United States: 4
Illinois, United States: 1
Louisiana, United States: 2
Maryland, United States: 1
Massachusetts, United States: 1
Michigan, United States: 1
Mississippi, United States: 1
Missouri, United States: 3
Nevada, United States: 1
New Jersey, United States: 1
New York, United States: 4
North Carolina, United States: 3
Ohio, United States: 2
Oklahoma, United States: 1
Oregon, United States: 1
Rhode Island, United States: 1
South Carolina, United States: 3
Tennessee, United States: 4
Texas, United States: 7
Virginia, United States: 1
Washington, United States: 1

Sample of listed locations

Accel Research - Birmingham — Birmingham, Alabama, 35216, United States — Site recruitment status not specified in the registry data
Central Research Associates, LLC — Birmingham, Alabama, 35205, United States — Site recruitment status not specified in the registry data
AMR Mobile — Mobile, Alabama, 36608, United States — Site recruitment status not specified in the registry data
Sun City Clinical Research — Glendale, Arizona, 85304, United States — Site recruitment status not specified in the registry data
Scottsdale Clinical Trials — Scottsdale, Arizona, 85260, United States — Site recruitment status not specified in the registry data
Lynn Institute of the Ozarks — Little Rock, Arkansas, 72204, United States — Site recruitment status not specified in the registry data
Hope Clinical Research — Canoga Park, California, 91303, United States — Site recruitment status not specified in the registry data
Marvel Clinical Research — Huntington Beach, California, 92647, United States — Site recruitment status not specified in the registry data
Eximia Research-CA, LLC — La Mesa, California, 91942, United States — Site recruitment status not specified in the registry data
Long Beach Research Institute — Long Beach, California, 90805, United States — Site recruitment status not specified in the registry data
Paradigm Clincial Research - Modesto — Modesto, California, 95355, United States — Site recruitment status not specified in the registry data
Pasadena Clinical Trials — Pasadena, California, 91101, United States — Site recruitment status not specified in the registry data
Artemis Institute for Clinical Research - Riverside — Riverside, California, 92503, United States — Site recruitment status not specified in the registry data
Velocity Clinical Research -San Bernardino — San Bernardino, California, 92408, United States — Site recruitment status not specified in the registry data
Alpine Clinical Research Center — Boulder, Colorado, 80301, United States — Site recruitment status not specified in the registry data
Paradigm Clinical Research - Wheat Ridge — Wheat Ridge, Colorado, 80033, United States — Site recruitment status not specified in the registry data
Chase Medical Research — Waterbury, Connecticut, 06708, United States — Site recruitment status not specified in the registry data
Velocity Clinical Research - Washington DC — Washington D.C., District of Columbia, 20016, United States — Site recruitment status not specified in the registry data
Neurology Offices of South Florida, PLLC — Boca Raton, Florida, 33428, United States — Site recruitment status not specified in the registry data
Accel Research - Deland — DeLand, Florida, 32720, United States — Site recruitment status not specified in the registry data
Velocity Clinical Research - Hallandale Beach — Hallandale, Florida, 33009, United States — Site recruitment status not specified in the registry data
CNS Healthcare - Jacksonville — Jacksonville, Florida, 32256, United States — Site recruitment status not specified in the registry data
Health Awareness, Inc. - Jupiter — Jupiter, Florida, 33458, United States — Site recruitment status not specified in the registry data
3Sync Research -Miami Lakes — Miami Lakes, Florida, 33014, United States — Site recruitment status not specified in the registry data
Aqualane Clinical Research — Naples, Florida, 34105, United States — Site recruitment status not specified in the registry data

Study details

Start date: November 21, 2025
Primary completion date: April 6, 2027
First posted: November 17, 2025

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT07231419
Registry last updated: July 20, 2026
QualifiedStudies registry data refreshed: September 21, 2026

View NCT07231419 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Diabetic Neuropathy studies | Clinical trial FAQ